Protein is a cornerstone nutrient for maintaining overall health, but its significance becomes especially prominent for those ...

The World Health Organisation plans to officially back the use of weight-loss drugs to treat obesity in adults for the first ...

Eli Lilly reported a strong revenue jump driven by the blockbuster performance of its weight loss and diabetes drugs, ...

The WHO's conditional recommendation will be officially released in August, as part of new guidelines on treating obesity.

Effective July 1, 2025, CVS Caremark will place Wegovy injection 2.4 mg as preferred on its commercial template formularies.

Hardworking Tennesseans have tried changes to diets and exercise to lose weight and maintain healthy lifestyles, but ...

With mounting evidence that an infodemic of disinformation about GLP-1 weight loss medicines has become America's second obesity crisis, the National Consumers League (NCL) – a leading non-profit ...

Eli Lilly said sales of weight loss drug Zepbound and diabetes treatment Mounjaro soared in the first quarter.

The World Health Organization plans to endorse weight-loss drugs for treating adult obesity, marking a shift in addressing ...

Separately, CVS Health said that its pharmacy benefit management unit would drop Lilly's Zepbound as a preferred product from ...